ATXS NASDAQ
Astria Therapeutics, Inc.
1W: +1.5%
1M: +3.7%
3M: +73.6%
1Y: +43.1%
3Y: -11.6%
5Y: -8.3%
$12.58
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2025-10-14
Earliest Filing
2026-01-23
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named ATXS in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS INC | acquirer | Target company in the merger with BioCryst Pharmaceuticals, Inc. | 2026-01-23 | View |
| BCRX BIOCRYST PHARMACEUTICALS INC | acquirer | Target company in the merger agreement with BioCryst Pharmaceuticals, Inc. | 2025-10-14 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR